The biggest healthcare deals in the third quarter of 2021 were for companies focused on mRNA drug discovery, digital care and cybersecurity, according to CB Insights' third-quarter venture capital report.
Here are the 10 biggest healthcare deals in 2021's third quarter:
- Chinese mRNA drugmaker Abogen raised $700 million in a series C funding round.
- Cambridge, Mass.-based mRNA drugmaker Laronde raised $440 million in a series B funding round.
- Columbus, Ohio-based healthcare automation company Olive raised $400 million in a series H funding round.
- Chinese artificial intelligence drug discovery company XtalPi raised $400 million in a series D funding round.
- Charlotte, N.C.-based care platform Cityblock Health raised $400 million in a series D funding round.
- San Francisco-based digital healthcare provider Carbon Health raised $350 million in a series D funding round.
- Chinese online insurance firm Zhiyuan Zhongan raised $309 million.
- Chinese healthcare payment and digital care platform MediTrust Health raised $308 million in a series C funding round.
- Santa Clara, Calif.-based cloud security provider Netskope raised $300 million in a series H funding round.
- Boston-based cyber defense platform developer Cybereason raised $275 million in a series F funding round.